+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05673148

Evaluating Total Ablative Therapy Plus Standard Chemotherapy Versus Standard Chemotherapy Alone for Limited Metastatic Colorectal Cancer in a Randomized Phase II Trial

Led by Alliance for Clinical Trials in Oncology · Updated on 2026-11-03

146

Participants Needed

195

Research Sites

214 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether adding total ablative therapy TAT to the usual systemic treatment improves outcomes for patients with advanced colorectal cancer that has spread to up to four body sites. The study compares this combined approach to systemic therapy alone in patients newly diagnosed with limited metastatic colorectal cancer. This phase II trial aims to assess overall survival and other important outcomes while monitoring side effects. Participants are randomly assigned to one of two groups. One group receives total ablative therapy, which may include stereotactic ablative radiotherapy SABR, surgical removal of tumors, or microwave ablation, along with standard chemotherapy. The other group receives only the standard chemotherapy. Throughout the trial, patients undergo imaging scans like CT, MRI, or PETCT and may have endoscopic exams and optional blood sample collections. After treatment, patients are followed for up to five years. During the trial, participants have regular scans to monitor the cancers status and any recurrence. Researchers evaluate overall survival from the time of randomization and track event-free survival, adverse events, and time to local recurrence in the group receiving ablative therapy. The study includes detailed assessments to understand treatment effects and safety over a long-term follow-up period, lasting up to five years after registration.

CONDITIONS

Brief Title

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Research Team

E

Eric D. Miller, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here